Ahmed Asaad

Prof. Ahmed Asaad

MD

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
Shamshul AnsariShamshul Ansari
Shamshul Ansari
RJRajesh K Jha
Rajesh K Jha
SMShyam Kumar Mishra
Shyam Kumar Mishra
BTBirendra Raj Tiwari
Birendra Raj Tiwari
AAAhmed Asaad
Ahmed Asaad
Staphylococcus aureus normally colonizes the nasal cavity and pharynx. After breaching the normal habitat, the organism is able to cause a number of infections at any site of the body. The development of antibiotic resistance has created a global challenge for treating infections. Therefore, protection by vaccines may provide valuable measures. Currently, several vaccine candidates have been prepared which are either in preclinical phase or in early clinical phase, whereas several candidates have failed to show a protective efficacy in human subjects. Approaches have also been made in the development of monoclonal or polyclonal antibodies for passive immunization to protect from S. aureus infections. Therefore, in this review we have summarized the findings of recently published scientific literature to make a concise report.

1 March 2017 in Journal of Herbal Medicine
Verified
Journal Article
Closed access
MSMohammed Helmy Faris Shalayel
Mohammed Helmy Faris Shalayel
AAAhmed Asaad
Ahmed Asaad
MQMohammed Ansar Qureshi
Mohammed Ansar Qureshi
AEAmar Babiker Elhussein
Amar Babiker Elhussein

1 February 2021 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
AAAhmed Asaad
Ahmed Asaad
Shamshul AnsariShamshul Ansari
Shamshul Ansari
SASoma Elsayed Ajlan
Soma Elsayed Ajlan
SASamah Mohammed Awad
Samah Mohammed Awad
Objective: This cross-sectional study aims to determine the prevalence and associated risk factors of biofilm-producing A. baumannii nosocomial isolates from a tertiary care hospital, as well as to investigate any possible association of biofilm formation with the distribution of biofilm-related genotypes and antibiotic resistance phenotypes. Methods: A total of 94 non-duplicate A. baumannii nosocomial isolates were identified, their biofilm formation was quantitatively detected using the modified microtiter plate assay, and their susceptibilities to different antibiotics were determined using the breakpoint method. Isolates were then subjected to PCR assays targeting bap, ompA and blaPER-1 genes. Results: The majority (70.1%) of isolates were biofilm producers. The most prevalent biofilm gene was ompA (63.8%), followed by bap (13.8%) and blaPER-1 (10.6%). The presence of multi- and extensive-drug resistance (MDR and XDR) was significantly associated with biofilm producers (p = 0.017 and 0.002, respectively). The length of hospital stay (aOR= 0.023), the presence of ompA gene (aOR = 0.286) or bap gene (aOR = 0.346), ampicillin/sulbactam resistance (aOR = 1), and the presence of MDR (aOR = − 0.329) or XDR (aOR = − 0.252) were considered significant risk factors associated with biofilm-producing isolates. Conclusion: The high prevalence of biofilm-producing MDR and XDR nosocomial isolates in this study is worrisome and alarming. Characterization of risk factors could help control the continuous selection and transfer of this serious A. baumannii phenotype inside hospitals and improve the quality of patients’ care.

19 January 2016 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
MAMohamed Saeed Zayed Al-Ayed
Mohamed Saeed Zayed Al-Ayed
AAAhmed Asaad
Ahmed Asaad
MQMohamed Ansar Qureshi
Mohamed Ansar Qureshi
HAHany Attia
Hany Attia
AAAbduljabbar Hadi AlMarrani
Abduljabbar Hadi AlMarrani
Much effort has focused on examining the inhibitory effect of Salvadora persica (miswak) on oral microorganisms, but information concerning its antibacterial activity against other human pathogens, particularly multidrug resistant (MDR) isolates, is scarce. Therefore, this study aimed to assess the in vitro antibacterial activities of Salvadora persica L. extracts against 10 MDR bacterial clinical isolates other than oral pathogens. The antibacterial activity of aqueous and methanol miswak extracts was assessed using the agar dilution and minimum inhibitory concentration (MIC) methods. Overall, the 400 mg/mL of miswak extract was the most effective on all strains. The methanol extract exhibited a stronger antibacterial activity against Gram‐negative (3.3–13.6 mm) than Gram‐positive (1.8–8.3 mm) bacteria. The lowest MIC value was seen for E. coli (0.39, 1.56 µg/mL), followed by Streptococcus pyogenes (1.56 µg/mL). The highest MIC value (6.25, 12.5 µg/mL) was recorded for methicillin‐resistant Staphylococcus aureus (MRSA), Acinetobacter baumannii, and Stenotrophomonas maltophilia. This study demonstrates, for the first time, the moderate to strong antibacterial activity of miswak extracts against all tested MDR‐pathogens. Methanol extract appears to be a potent antimicrobial agent that could be considered as complementary and alternative medicine against resistant pathogens. Further studies on a large number of MDR organisms are necessary to investigate and standardize the inhibitory effect of miswak extracts against these emerging pathogens.

1 April 2012 in Journal of Infection and Public Health
Verified
Journal Article
Closed access
AAAhmed Asaad
Ahmed Asaad
JAJobran Miree Alqahtani
Jobran Miree Alqahtani

9 June 2014 in BMC Public Health
Verified
Journal Article
Open access
PDF file
JAJobran Alqahtani
Jobran Alqahtani
SASaeed A Abu-Eshy
Saeed A Abu-Eshy
AMAhmed Mahfouz
Ahmed Mahfouz
AEAwad A El-Mekki
Awad A El-Mekki
AAAhmed Asaad
Ahmed Asaad
The objectives of the study were to study the seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections among health college students (HS) and health care workers (HCWs) in the Najran Region of south-western Saudi Arabia and to study the students’ knowledge of occupational exposure to blood-borne viral infections.